Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burke, R. E.
Right arrow Articles by Marsden, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burke, R. E.
Right arrow Articles by Marsden, C. D.
NEUROLOGY 1986;36:160
© 1986 American Academy of Neurology

Torsion dystonia

A double-blind, prospective trial of high-dosage trihexyphenidyl

Robert E. Burke, Stanley Fahn and C. David Marsden

Department of Neurology, The College of Physicians and Surgeons, Columbia University, New York, NY; and the University Department of Neurology, Institute of Psychiatry and King's College Hospital Medical School, London, England.

We studied trihexyphenidyl in the treatment of torsion dystonia in a prospective, double-blind crossover protocol. Thirty-one patients completed the protocol. Twenty-two (71%) had a clinically significant response. After a mean follow-up of 2.4 years, 68% of patients continued to take trihexyphenidyl, and 42% continued to show a considerable or dramatic benefit. The 30-mg dose used was generally well tolerated. High-dosage trihexyphenidyl therapy is effective in the management of torsion dystonia.

Address correspondence and reprint requests to Dr. Burke, Neurological Institute, 710 W. 168th Street, New York, NY 10032.

Supported by the Dystonia Medical Research Foundation. In New York, this study was conducted at the Dystonia Clinical Research Center at Columbia University. R.E.B. is the recipient of an NINCDS Teacher-Investigator Award (#1 Ko7 NS00748–01A1).

Accepted for publication June 4, 1985.




This article has been cited by other articles:


Home page
Journal of Pharmacy PracticeHome page
K. Dashtipour, M. Barahimi, and S. Karkar
Cervical Dystonia
Journal of Pharmacy Practice, December 1, 2007; 20(6): 449 - 457.
[Abstract] [PDF]


Home page
J Child NeurolHome page
T. D. Sanger, A. Bastian, J. Brunstrom, D. Damiano, M. Delgado, L. Dure, D. Gaebler-Spira, A. Hoon, J. W. Mink, S. Sherman-Levine, et al.
Prospective Open-Label Clinical Trial of Trihexyphenidyl in Children With Secondary Dystonia due to Cerebral Palsy
J Child Neurol, May 1, 2007; 22(5): 530 - 537.
[Abstract] [PDF]


Home page
NEJMHome page
A. Kupsch, R. Benecke, J. Muller, T. Trottenberg, G.-H. Schneider, W. Poewe, W. Eisner, A. Wolters, J.-U. Muller, G. Deuschl, et al.
Pallidal Deep-Brain Stimulation in Primary Generalized or Segmental Dystonia
N. Engl. J. Med., November 9, 2006; 355(19): 1978 - 1990.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. Tarsy and D. K. Simon
Dystonia
N. Engl. J. Med., August 24, 2006; 355(8): 818 - 829.
[Full Text] [PDF]


Home page
PediatricsHome page
S. L. Merhar and D. L. Gilbert
Clinical (Video) Findings and Cerebrospinal Fluid Neurotransmitters in 2 Children With Severe Chronic Bilirubin Encephalopathy, Including a Former Preterm Infant Without Marked Hyperbilirubinemia
Pediatrics, November 1, 2005; 116(5): 1226 - 1230.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. Greene
Deep-Brain Stimulation for Generalized Dystonia
N. Engl. J. Med., February 3, 2005; 352(5): 498 - 500.
[Full Text] [PDF]


Home page
J Child NeurolHome page
T. D. Sanger
Pathophysiology of Pediatric Movement Disorders
J Child Neurol, January 1, 2003; 18(1_suppl): S9 - S24.
[Abstract] [PDF]


Home page
Neurorehabil Neural RepairHome page
C. Green, C. Proch, and S. E. Gara
Review Article : The Changing Face of Cerebral Palsy: A Review of the Disorder and Its Treatment
Neurorehabil Neural Repair, January 1, 1997; 11(4): 245 - 253.
[Abstract] [PDF]


Home page
Arch NeurolHome page
B. Ford, P. Greene, E. D. Louis, G. Petzinger, S. B. Bressman, R. Goodman, M. F. Brin, S. Sadiq, and S. Fahn
Use of Intrathecal Baclofen in the Treatment of Patients With Dystonia
Arch Neurol, December 1, 1996; 53(12): 1241 - 1246.
[Abstract] [PDF]


Home page
J Child NeurolHome page
M. R. Pranzatelli
Oral Pharmacotherapy for the Movement Disorders of Cerebral Palsy
J Child Neurol, November 1, 1996; 11(1_suppl): S13 - S22.
[Abstract] [PDF]


Home page
Neurorehabil Neural RepairHome page
I. M. Siegel, V. Sahgal, and M. Barany
Focal Foot Dystonia: Two Cases Treated by Surgical Release
Neurorehabil Neural Repair, January 1, 1989; 3(1): 19 - 25.
[Abstract] [PDF]


Home page
Arch NeurolHome page
W. T. Longstreth Jr, T. D. Koepsell, and G. van Belle
Clinical Neuroepidemiology: II. Outcomes
Arch Neurol, November 1, 1987; 44(11): 1196 - 1202.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.